RecruitingNot ApplicableNCT07632742
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial
Sponsor
Northwestern University
Enrollment
180 participants
Start Date
Jun 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Eligibility
Sex: MALEMin Age: 18 YearsMax Age: 100 Years
Inclusion Criteria2
- Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
- Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion Criteria4
- Patients who lack decisional capacity
- Patients unable to read/speak English
- Patients who are on a blood thinner (anticoagulation medication)
- Patients who do not have internet access to complete postoperative surveys
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMagneto 150 holmium laser
The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser
DEVICEMoses 2.0 holmium laser
The HoLEP procedure will be performed using the Moses 2.0 holmium laser
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07632742
Related Trials
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT0651114120 locations
Water Vapor Thermal Therapy Versus Ejaculation-Sparing Bipolar Transurethral Enucleation for Benign Prostatic Hyperplasia
NCT076488881 location
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NCT0684925820 locations
Spinal Versus General Anesthesia in Open Simple Prostatectomy
NCT076434151 location
Ejaculatory-Sparing HoLEP vs Standard HoLEP
NCT076312861 location